Archive for the ‘Int J Neuropsychopharm’ Category
Neuroscientist Stanley Rapoport hasn’t had much luck with his co-authors.
Recently, we’ve reported on multiple retractions of papers co-authored by Rapoport after three different first authors were found to have committed misconduct. Now, the fallout from one of those cases had led to four more retractions, bringing Rapoport’s total to 12.
The latest batch of retractions stem from the actions of Jagadeesh Rao.
Here’s the first notice, issued by Psychopharmacology: